A detailed history of Citigroup Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Citigroup Inc holds 26,755 shares of NKTX stock, worth $52,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,755
Previous 37,824 29.26%
Holding current value
$52,439
Previous $69,000 36.23%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

SELL
$1.51 - $2.22 $16,714 - $24,573
-11,069 Reduced 29.26%
26,755 $44,000
Q1 2025

May 12, 2025

SELL
$1.37 - $2.53 $4,186 - $7,731
-3,056 Reduced 7.48%
37,824 $69,000
Q4 2024

Feb 12, 2025

BUY
$2.17 - $4.34 $930 - $1,861
429 Added 1.06%
40,880 $101,000
Q3 2024

Nov 12, 2024

SELL
$4.52 - $8.0 $55,067 - $97,464
-12,183 Reduced 23.15%
40,451 $182,000
Q2 2024

Aug 12, 2024

BUY
$5.27 - $10.82 $17,143 - $35,197
3,253 Added 6.59%
52,634 $311,000
Q1 2024

May 10, 2024

BUY
$5.59 - $15.71 $251,857 - $707,814
45,055 Added 1041.49%
49,381 $533,000
Q4 2023

Feb 09, 2024

SELL
$1.31 - $6.6 $1,199 - $6,045
-916 Reduced 17.47%
4,326 $28,000
Q3 2023

Nov 09, 2023

SELL
$1.39 - $2.29 $7,874 - $12,972
-5,665 Reduced 51.94%
5,242 $7,000
Q2 2023

Aug 10, 2023

BUY
$2.19 - $5.17 $20,329 - $47,993
9,283 Added 571.61%
10,907 $23,000
Q1 2023

May 11, 2023

BUY
$3.37 - $6.3 $117 - $220
35 Added 2.2%
1,624 $5,000
Q4 2022

Feb 09, 2023

SELL
$5.14 - $14.35 $744,991 - $2.08 Million
-144,940 Reduced 98.92%
1,589 $9,000
Q3 2022

Nov 10, 2022

BUY
$12.27 - $18.39 $1.2 Million - $1.8 Million
98,085 Added 202.47%
146,529 $1.93 Million
Q2 2022

Aug 10, 2022

BUY
$7.77 - $19.44 $363,332 - $909,033
46,761 Added 2778.43%
48,444 $597,000
Q1 2022

May 12, 2022

SELL
$8.66 - $14.99 $49,665 - $85,967
-5,735 Reduced 77.31%
1,683 $19,000
Q4 2021

Feb 10, 2022

SELL
$12.79 - $26.88 $354,206 - $744,414
-27,694 Reduced 78.87%
7,418 $114,000
Q3 2021

Nov 10, 2021

BUY
$26.67 - $38.76 $936,437 - $1.36 Million
35,112 New
35,112 $976,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $95.4M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.